PTPN11 and cancer: In many cancer types, SHP2 is hyperactive due to mutations of the Ptpn11 gene, which encodes SHP2, or to aberrant signaling from protein tyrosine kinases, and functions as a proto‐oncogene (Ran et al,2016).